ANIMATION

Heart Sciences MyoVista Wavelet ECG Technology

Share this animation:

Coronary heart disease, or CHD, is a leading cause of death in men and women, effecting an estimated 16.5 million adults in the United States. Due to its limitations, current ECG testing leaves many patients undiagnosed.

XVIVO partnered with Heart Sciences to develop an animation describing their MyoVista Wavelet ECG technology that can detect changes in the heart from CHD and other diseases before symptoms appear.

MyoVista Wavelet ECG is revolutionizing conventional electrocardiography, providing significant clinical, technical, and economical advantages for healthcare providers over conventional ECG. This technology now provides physicians more information to enable better risk stratification to identify heart disease earlier.

Share It:
Contact XVIVO

Client


Heart Sciences MyoVista Wavelet ECG Technology

XVIVO was an absolute pleasure to work with. Our project with XVIVO was our very first animation project and their team guided us through the process with no difficulty. The people that we worked with were very talented and made the whole process enjoyable. Their attention to the details was superb. We are completely satisfied with the end result and is a product that we can continue to use in the future. We will work with them again.

Manager, New Business Development, Ajinomoto
Share this animation: